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doi:10.1016/j.ejvs.2008.05.004Abstract The aorto-esophageal fistula is a well-recognized and potentially fatal complication
of thoracic aortic surgery. Several strategies regarding its prevention and subsequent manage-
ment have been described. We report the management of a large midthoracic fistula compli-
cating redo thoraco-abdominal aortic surgery by the placement of covered stents in the aorta
and esophagus to successfully exclude the lesion.
While long term durability is uncertain, endografts and long-term antibiotics provide a ther-
apeutic option for palliation in patients unfit for immediate surgery.
ª 2008 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.Introduction
The aortoesophageal fistula (AEF) is a well-recognized com-
plication of thoracic aortic surgery; it is universally fatal in
untreated patients, but operative repair is challenging and
fraught with high morbidity and mortality rates.
We describe a novel approach based on endoluminal
repair of the mediastinal lesion.
Case Report
A 61-year-old man was referred to our Institution with fever,
thoracic pain and several episodes of gastro-intestinal, MD, Department of Vascu-
a Olgettina, 60, 20132 Milan,
02 2643 7148.
(G. Melissano).
ty for Vascular Surgery. Publishebleeding. Blood tests revealed severe anemia, coagulation
impairment andelevated inflammatorymarkers. Thepatient
had a history of myocardial infarction, COPD and repair of
a ruptured descending thoracic aneurysm. Two years later,
a type III thoraco-abdominal aortic aneurysm grafting was
performed for progression of the disease.
An emergent 64-row multislice CT angiogram revealed
a pseudoaneurysm of the proximal anastomosis (mid-
thoracic aorta) with perigraft fluid collection and gas
bubbles in close proximity to the oesophagus. Collateral
findings revealed patency of a large intercostal branch
reimplanted during the previous operation and dilatation of
the Carrell patch (5 cm) with patency of the renal and
splanchnic vessels (Fig. 1).
Due to severe comorbidities, the patient was considered
unfit for open repair and an endovascular approach to AEF
was planned. Medical treatment was initially started with
broad-spectrum antibiotics, morphine, blood and plasma
transfusions to stabilize the patient, however, thed by Elsevier Ltd. All rights reserved.
Figure 1 Axial and multiplanar scans of preoperative computed tomography demonstrate a multi- sepimented mid-thoracic
aortic pseudoaneurysm (*) with septic perigraft collection. The patent intercostal artery is visible at T10 (arrow).
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bleeding with shock and respiratory distress. He was
immediately intubated, fluid-resuscitated and referred to
the operatory room. A rifampicin soaked Zenith TX2-P 42
162 mm (William Cook Europe, Bjaerverskov, Denmark) was
deployed in order to fit in a 38 mm diameter of the proxi-
mal aorta. The proximal anastomosis was covered, care-
fully preserving the previously reimplanted intercostal
artery, visible at the intraoperative angiogram. The patient
immediately recovered hemodynamic stability and awak-
ened neurologically intact. On the 2nd postoperative day,
a CT scan confirmed the successful exclusion of theFigure 2 Axial and 3D scans of postoperative computed tomogra
mediastinal abscess. Note the percutaneous drainage of the perigrpseudoaneurysm; at the same time, a 8 Fr. percutaneous
non-locking pigtail catheter (Boston Scientific Corporation,
Natick, MA) was placed under CT-guidance to drain the
perigraft collection. Microbiologic cultures of the abscess
were positive for Escherichia coli and Corynebacterium
species. Culture-specific parenteral antibiotics - piperacillin/
tazobactam, fluconazole and teicoplanin - were started.
To evaluate the gastroenteric lesion, a Gastrografin
(Schering, Berlin, Germany) swallow study was performed
on 8th postoperative day with evidence of an extensive,
persistent leak, from the esophagus lumen into the peri-
aortic abscess. An esophageal nitinol stent 24 80 mm withphy show the absence of aortic leaks and the resolution of the
aft collection (arrow).
Secondary Aortoesophageal Fistula 299a polyurethane coating: Nitis - S (Taewong Medical, Seoul,
Korea), was deployed to exclude the fistula; meanwhile the
periaortic drainage was left in-situ. The diameter and
length of stent were chosen according to the size of esoph-
ageal lumen estimated at the swallow study.
The patient did well: his fever subsided and laboratory
findings revealed progressive resolution of the inflamma-
tory markers. At 1 and 3 weeks after the procedure,
reassessment CTs showed resolution of the mediastinal
collection (Fig. 2). One month after the procedure, the
drainage was removed and the patient was weaned from to-
tal parenteral nutrition, gradually resuming a normal diet.
Suppressive broad spectrum antibiotic therapy was given.
At 5 months follow-up, a satisfactory recovery was ob-
served: no fever, no blood inflammatory markers elevation
and no new episodes of gastro-intestinal bleeding were
recorded. The CT scan revealed persistent resolution of
the mediastinal collection and complete exclusion of the
pseudoaneurysm.
Discussion
Although several strategies have been reported in the
literature including endovascular and in-situ repair with
cryopreserved homograft, no general consensus exists on
the optimal approach to an AEF.1 Coselli et al. reports that
over 60% of patients die within 6 hours from the presenta-
tion of symptoms. Overall mortality rates of open repair
range from 30% to 80%.2 Therefore, a less-invasive approach
may be particularly appealing in the presence of a frozen
chest from previous aortic surgery and severe comorbid
conditions.
Endovascular stent graft repair may itself cause an
esophageal fistula by aortic erosion particularly in tortuous
segments, however it had proved to be an appealing and
effective durable option for patients with infected pseu-
doaneurysms of the thoracic aorta. Stanley et al.3
reported successful endovascular treatment of four
patients with mycotic thoracic aortic aneurysms. There
has always been concern about persistent infection when
a stent graft is deployed in an infected field, however, in
situ prosthetic reconstruction is often unavoidable, even
with open repair.The risk of persistent infection may be high in situations
where contamination from the esophageal lesion is ongo-
ing. Ting et al.4 reported a poor outcome in two of seven
patients with persistent esophageal lesions resulting in con-
tinued contamination of the stent-graft.
Mok et al.5 documented a case of successful closure of
a small esophageal fistula by injection of fibrin sealant,
but this result has not been reproduced and did not match
with our case where extensive esophageal lesions were
documented. Fistulas between the esophagus and tracheo-
bronchial tree have been effectively managed with covered
stenting of either the esophagus or the airways. Recently
a parallel placement of covered retrievable expandable
metallic stents has been advocated as a safe and effective
procedure for the palliative treatment of malignant esoph-
ageal and tracheobronchial strictures.6
To our knowledge, this is the first reported case of
double endoluminal approach for AEF. Long term durability
is uncertain and open treatment is still the first choice,
however, endografts and long-term antibiotics provide
a compassionate therapeutic option for temporary pallia-
tion in patients unfit for immediate surgery.
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